American Shared Hospital Services (NYSEAMERICAN:AMS) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a report released on Thursday. The firm issued a hold rating on the stock.

American Shared Hospital Services Price Performance

Shares of NYSEAMERICAN AMS opened at $3.19 on Thursday. The company has a market capitalization of $20.19 million, a price-to-earnings ratio of 39.88 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.98 and a current ratio of 1.98. American Shared Hospital Services has a 52-week low of $2.16 and a 52-week high of $3.69.

American Shared Hospital Services (NYSEAMERICAN:AMS) last announced its earnings results on Tuesday, May 14th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). The firm had revenue of $5.22 million during the quarter, compared to analysts’ expectations of $5.01 million. American Shared Hospital Services had a net margin of 2.50% and a return on equity of 4.29%. Sell-side analysts expect that American Shared Hospital Services will post 0.29 EPS for the current fiscal year.

Institutional Trading of American Shared Hospital Services

An institutional investor recently bought a new position in American Shared Hospital Services stock. Empowered Funds LLC acquired a new position in shares of American Shared Hospital Services (NYSEAMERICAN:AMS) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned 0.17% of American Shared Hospital Services at the end of the most recent quarter. 23.16% of the stock is owned by hedge funds and other institutional investors.

American Shared Hospital Services Company Profile

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.